Related Experiment Video
Updated: Aug 12, 2025

High-speed Video Microscopy Analysis for First-line Diagnosis of Primary Ciliary Dyskinesia
Published on: January 19, 2022
A Novel DNAH9 Gene Mutation Causing Primary Ciliary Dyskinesia With an Unusual Association of Jejunal Atresia in a
Hasan M Isa1,2, Fatema A Alkharsi2, Maryam Y Busehail2
1Department of Pediatrics, Arabian Gulf University, Manama, BHR.
Insights
Primary ciliary dyskinesia (PCD) is a rare genetic disorder affecting cilia function. This case highlights a novel DNAH9 mutation in a patient with jejunal atresia and developmental delay.
Area of Science:
- Genetics
- Rare Diseases
- Pediatrics
Background:
- Primary ciliary dyskinesia (PCD) is a rare autosomal recessive genetic disorder impacting cilia function in multiple organs.
- PCD prevalence is estimated at 1 in 15,000-20,000 individuals, characterized by chronic sinusitis, bronchiectasis, and situs inversus in 50% of cases.
Observation:
- This report details a unique case of PCD in Bahrain.
- The patient presented with type IIIb jejunal atresia and developmental delay secondary to vitamin B12 deficiency.
- Genetic analysis revealed a novel DNAH9 gene mutation in a compound heterozygous state.
Findings:
- The study identifies a new DNAH9 mutation associated with primary ciliary dyskinesia.
- This case presents a rare co-occurrence of PCD with jejunal atresia and vitamin B12 deficiency-related developmental delay.
- Early diagnosis and intervention are crucial for preventing irreversible lung damage in PCD patients.
Implications:
- This case expands the known spectrum of DNAH9 mutations and their clinical manifestations.
- Highlights the importance of considering rare genetic disorders in complex pediatric cases.
- Emphasizes the need for multicenter collaborations to improve PCD diagnosis and treatment outcomes.
Abstract:
Primary ciliary dyskinesia (PCD) is a rare autosomal recessive genetic disorder. It is caused by a defect in the action of the cilia lining multiple organs of the body, including the lungs, the sinuses, hepatobiliary and reproductive organs. In general, the estimated prevalence of this condition is one in 15,000-20,000 individuals. It is characterized by the triad of chronic sinusitis, bronchiectasis, and situs inversus, which occurs in 50% of the cases. It can be associated with other diseases too. Genetic studies can aid in confirming the diagnosis of this condition. A high degree of suspicion about PCD among pediatricians, neonatologists, otorhinolaryngologists, and pulmonologists is essential to make early referrals of patients before they develop irreversible lung damage. Hence, early diagnosis and appropriate treatment are very important. Multicenter collaborations might improve the quality of treatment and patient outcomes. Here, we discuss a case of PCD with a unique association with type IIIb jejunal atresia, and developmental delay secondary to vitamin B12 deficiency. Moreover, the patient was found to have a novel DNAH9 gene mutation in a compound heterozygous state. This is the first case of this rare disease to be reported from Bahrain. This case report is also associated with an extensive literature review.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon...
DNA Helicases
Cystic Fibrosis: Management
Sinus disease and chronic...
Animal Mitochondrial Genetics

